Conversely, in cancer cells, the continuous activation of the PI3K/Akt/mTOR pathway serves as a key driving force for the metabolic adaptability of these cells, contributing to their enhanced survival, proliferation, and invasive capabilities 117. This evidence concerns the gene AKT1 and cancer.